Tokyo, Japan

Daisuke Nishizawa

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Spotlight on Inventor Daisuke Nishizawa

Introduction:

Daisuke Nishizawa is a talented inventor based in Tokyo, Japan, known for his innovative work in the field of evaluating drug sensitivity and disease vulnerability. With a total of 2 patents to his name, Nishizawa's contributions have significantly impacted the medical research landscape.

Latest Patents:

1. Method for evaluating drug sensitivity and disease vulnerability by analyzing cyclic AMP responsive element binding protein gene: Nishizawa's groundbreaking invention provides a method for predicting individual differences in drug sensitivity and disease vulnerability by analyzing gene polymorphisms of a cyclic AMP responsive element binding protein gene. This method associates gene polymorphisms with drug sensitivity and disease vulnerability.

2. Method of evaluating drug sensitivity by analyzing GIRK channel genes: Nishizawa's second patent involves a method for evaluating drug sensitivity and disease vulnerability by linking gene polymorphisms in GIRK channel genes to individual drug sensitivity and disease vulnerability.

Career Highlights:

Nishizawa has worked with prestigious institutions in Tokyo, including the Tokyo Metropolitan Organization for Medical Research and the Tokyo Metropolitan Institute of Medical Science. His dedication to advancing medical research has led to significant breakthroughs in the field of personalized medicine.

Collaborations:

Throughout his career, Nishizawa has collaborated with esteemed colleagues such as Kazutaka Ikeda and Masakazu Hayashida. These partnerships have fostered a culture of innovation and excellence, resulting in impactful research projects and patents.

Conclusion:

Inventor Daisuke Nishizawa's focus on evaluating drug sensitivity and disease vulnerability showcases his commitment to improving personalized medicine practices. His patents reflect a deep understanding of genetic factors that influence individual responses to medication, highlighting the importance of tailored treatment approaches in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…